Pharma industry explained.
How drugs actually get developed, tested, priced, and sold, separated from the hype and the outrage cycle. Premium advertiser fit, broad audience, careful editorial judgment required.
What works in this niche
- Explaining the actual clinical trial pipeline and where drugs fail in plain terms
- Charts that show the cost structure and pricing math behind a specific drug
- The gap between what the trials show and how a drug is marketed, surfaced honestly
- Grounding abstract pricing debates in the documented economics
- Explicit separation of fact from allegation when covering industry practices
Format: 10 to 15 minute explainers over FDA-process graphics, pricing charts, and B-roll. First-person voice, popular narrative then mechanism then reality structure, 90-second re-hook.
Hook patterns that earn clicks
- Data shock: the cost of a drug course versus its development and manufacturing cost
- Question hook: how a drug approved for one condition ends up prescribed for ten others
- Contrarian: the drug controversy that the trial record tells very differently from the headline
Sub-niches to mine
Narrower angles inside this niche with room to own a lane.
- How a drug moves from molecule to pharmacy shelf and where most fail
- The economics behind drug pricing in different healthcare systems
- How off-label prescription became standard and what that means
- The gap between trial populations and real-world patient populations
- How patent strategy shapes which drugs get developed and which do not
Top performers we track
Anonymized to protect operators. Revenue figures are estimates from public engagement, not declared earnings.
Common pitfalls
- Stating allegations as fact without attribution to court records or documented findings
- Drifting into specific medical guidance about whether to take or avoid a drug
- Covering current regulatory debates in ways that pull the channel into political territory
- Presenting pharma as a monolith rather than explaining the structural incentives
FAQ
How do I cover drug pricing without taking a political side?
Explain the documented economics, the trial costs, the pricing structure, and the insurance dynamics without editorializing about what policy should be. The facts are striking enough on their own without requiring a policy conclusion.
How is this different from the pharma-scandals niche in the blocklist?
Pharma scandals is a niche built on cases of wrongdoing. This niche explains how the industry works structurally, including where incentives create problems, without centering each video on a crisis. Broader, more evergreen, more sustainable.
Why the higher RPM?
The finance and business framing combined with health content pulls this into premium inventory. We hold the range conservative while new channels calibrate.
Want the full pipeline tuned for pharma industry explained?
Script, five A/B titles, SEO description, and thumbnail. Tuned per channel archetype. From operators with 1B+ views.